Mismatch repair deficiency is not applicable as biomarker in cervical cancer, yet msh-2 has strong prognostic value

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2022)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要